Response to erythropoiesis-stimulating agents in patients with WHO-defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)

Guadalupe Antelo, Abhishek A. Mangaonkar, Giacomo Coltro, Ajinkya Buradkar, Terra L. Lasho, Christy Finke, Ryan Carr, Moritz Binder, Naseema Gangat, Aref Al-Kali, Michelle A. Elliott, Rebecca L. King, Matthew Howard, Megan E. Melody, William Hogan, Mark R. Litzow, Ayalew Tefferi, Martin E. Fernandez-Zapico, Rami Komrokji, Mrinal M. Patnaik

Research output: Contribution to journalLetter

Original languageEnglish (US)
JournalBritish journal of haematology
DOIs
StateAccepted/In press - Jan 1 2020

Keywords

  • ESA
  • MDS-RS
  • MDS/MPN-RS-T
  • erythropoiesis stimulating agents
  • myeloid leukaemia
  • sideroblastic anaemia

ASJC Scopus subject areas

  • Hematology

Cite this

Antelo, G., Mangaonkar, A. A., Coltro, G., Buradkar, A., Lasho, T. L., Finke, C., Carr, R., Binder, M., Gangat, N., Al-Kali, A., Elliott, M. A., King, R. L., Howard, M., Melody, M. E., Hogan, W., Litzow, M. R., Tefferi, A., Fernandez-Zapico, M. E., Komrokji, R., & Patnaik, M. M. (Accepted/In press). Response to erythropoiesis-stimulating agents in patients with WHO-defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T). British journal of haematology. https://doi.org/10.1111/bjh.16515